Here are relevant reports on : Pharmaceutical-Drug Delivery Market
-
Medical Plastics Market by Type (Engineering Plastics, HPP, Standard Plastics, Silicone, and Others), Application (Medical Disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others), Region - Global Forecast to 2024
The Medical Plastics Market is expected to grow from USD 22.8 billion in 2019 to USD 31.7 billion by 2024, at a compound annual growth rate (CAGR) of 6.8%. during the forecast period.SABIC (Saudi Arabia), BASF (Germany), Celanese (US), Evonik (Germany), Solvay (Belgium), and Covestro (Germany) are some of the leading market players. New product launch, agreement & collaboration, investment & expansion, and merger & acquisition were the major growth strategies adopted by the market players between 2017 and 2019 to enhance their regional presence and meet the growing demand for medical plastics in the emerging economies.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact On Medical Plastics Market by Type (Engineering Plastics and Standard Plastics), Application (Medical Disposables, Prosthetics, Medical Instruments & Tools and Drug Delivery) and Region - Global Forecast to 2021
The COVID-19 Impact On medical plastics market is expected to grow from USD 25.1 billion in 2020 to USD 29.4 billion by 2021 at a compound annual growth rate (CAGR) of 17.2% during the forecast period.SABIC (Saudi Arabia), BASF (Germany), Celanese (US), Evonik (Germany), Solvay (Belgium), and Covestro (Germany) are some of the leading market players in the global medical plastics market. CSR activities, increase in production, and partnerships were the major growth strategies adopted by the market players during this period to enhance their regional presence and meet the growing demand for medical plastics in the affected regions.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Global Forecast to 2029
The global injectable drug delivery market, valued at US$697.9B in 2023, is forecasted to grow at a 8.6% CAGR, reaching US$754.5B by 2024 and US$1,139.4B by 2029. Growth of this market is mainly driven by increasing prevalence of Infectious diseases, Increasing technological advancements and increasing funding scenarios for R&D.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030
The global smart pills market, valued at US$0.61B in 2023, is forecasted to grow at a 11.2% CAGR, reaching US$0.69B by 2024 and US$1.30B by 2030. The key factors driving the market growth include technological advancements and innovative healthcare developments.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
The global microfluidics market, valued at US$21.36B in 2023, is forecasted to grow at a 7.8% CAGR, reaching US$22.43B by 2024 and US$32.67B by 2029. The rising requirement of point-of-care diagnostics is an important factor, that helps to detect cancer, infectious diseases, and chronic illnesses, for which microfluidic devices are preferred due to their accuracy.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Ocular Implants Market by Product (Intraocular Lens, Glaucoma Implants, Orbital Implants), Application (Glaucoma surgery, Oculoplasty, Drug Delivery, Ocular Prosthesis), End User (Hospital, Specialty Eye Institutes) and Geography - Global Forecast to 2027
The global ocular implants market size is projected to reach USD 18,824.1 million by 2027 from USD 14,033.3 million in 2022, at a CAGR of 6.1% during the forecast period. Market is driven by factors such as increasing incidence of eye disorders such as age-related macular degeneration, glaucoma, corneal disease, and scleritis, increased time spent on virtual devices, and rising geriatric and diabetic population.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255M in 2023, is forecasted to grow at a 6.5% CAGR, reaching US$286M by 2024 and US$391M by 2029. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
The global active pharmaceutical ingredient market, valued at US$158.1B in 2023, is forecasted to grow at a 7.8% CAGR, reaching US$163.5B by 2024 and US$238.3B by 2029. The major factors driving the growth of this market include the increasing R&D funding, increasing outsourcing of active pharmaceutical ingredients manufacturing services, increase in healthcare expenditure.
- Published: May 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
